Concepedia

William Sun

WS

75

Publications

7.5K

Citations

38

H-Index

1990

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Incyte (United States)

University of Toronto

Mayo Clinic in Arizona

Princess Margaret Cancer Centre

William Sun is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and neuroscience.

ORCID

Top concepts

Publications per year

1990–2024

75

Publications

75

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Importance of the Intracellular Domain of NR2 Subunits for NMDA Receptor Function In Vivo

Rolf Sprengel, Bettina Suchanek, Carla Amico et al. · Cell · 1998 · 460 citations · Full text

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Haematologica · 2015 · 325 citations · Full text

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Julio Rosenstock, Salomon Banarer, Vivian Fonseca et al. · Diabetes Care · 2010 · 309 citations · Full text

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

Srđan Verstovšek, Jason Gotlib, Ruben A. Mesa et al. · Journal of Hematology & Oncology · 2017 · 286 citations · Full text

Rows per page

1–5 of 75